Healthcare Realty Trust Incorporated (NYSE:HR) Given Consensus Recommendation of "Reduce" by Analysts

Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) has received a consensus recommendation of "Reduce" from the five brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating and four have given a hold rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $17.00.

A number of equities analysts have recently commented on HR shares. Wells Fargo & Company dropped their price objective on Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating on the stock in a research note on Monday, March 10th. Wedbush dropped their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Scotiabank dropped their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating on the stock in a research note on Tuesday, February 25th. Finally, Wall Street Zen lowered Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Saturday.

Healthcare Realty Trust Trading Down 0.3%

NYSE HR traded down $0.04 during trading on Wednesday, hitting $14.50. 3,406,467 shares of the company traded hands, compared to its average volume of 3,148,950. Healthcare Realty Trust has a 12 month low of $14.25 and a 12 month high of $18.90. The business has a fifty day simple moving average of $15.44 and a 200 day simple moving average of $16.42. The company has a market capitalization of $5.10 billion, a P/E ratio of -8.15 and a beta of 0.92.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.39 EPS for the quarter, hitting analysts' consensus estimates of $0.39. The business had revenue of $288.86 million for the quarter, compared to analyst estimates of $297.39 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The firm's revenue for the quarter was down 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.39 earnings per share. Equities research analysts predict that Healthcare Realty Trust will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 23rd. Investors of record on Monday, May 12th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 8.55%. The ex-dividend date was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio (DPR) is presently -113.76%.

Insider Buying and Selling

In related news, Director Thomas N. Bohjalian acquired 2,500 shares of the stock in a transaction dated Tuesday, May 13th. The shares were bought at an average cost of $14.71 per share, for a total transaction of $36,775.00. Following the purchase, the director now owns 56,502 shares in the company, valued at approximately $831,144.42. This trade represents a 4.63% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is owned by company insiders.

Hedge Funds Weigh In On Healthcare Realty Trust

Hedge funds and other institutional investors have recently modified their holdings of the stock. Proficio Capital Partners LLC bought a new position in shares of Healthcare Realty Trust during the 4th quarter worth approximately $440,000. Steward Partners Investment Advisory LLC lifted its position in shares of Healthcare Realty Trust by 3,419.8% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 28,510 shares of the real estate investment trust's stock worth $483,000 after buying an additional 27,700 shares during the period. Geneos Wealth Management Inc. bought a new position in shares of Healthcare Realty Trust during the 4th quarter worth approximately $399,000. Barclays PLC lifted its position in shares of Healthcare Realty Trust by 116.2% during the 3rd quarter. Barclays PLC now owns 722,582 shares of the real estate investment trust's stock worth $13,117,000 after buying an additional 388,305 shares during the period. Finally, Russell Investments Group Ltd. lifted its position in shares of Healthcare Realty Trust by 22.4% during the 4th quarter. Russell Investments Group Ltd. now owns 2,772,522 shares of the real estate investment trust's stock worth $46,993,000 after buying an additional 508,045 shares during the period.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.